FURLANUT, Mario

FURLANUT, Mario  

DSMB - DIPARTIMENTO DI SCIENZE MEDICHE E BIOLOGICHE (attivo dal 01/01/2011 al 31/12/2016)  

Mostra records
Risultati 1 - 20 di 98 (tempo di esecuzione: 0.007 secondi).
Titolo Data di pubblicazione Autore(i) File
A SIMPLE METHOD TO MONITOR PLASMA CONCENTRATIONS OF OXCARBAZEPINE,CARBAMAZEPINE, THEIR MAIN METABOLITES AND LAMOTRIGINE IN EPILEPTIC PATIENTS 1-gen-2005 Franceschi, Loretta; Furlanut, Mario
A simple method to monitor serum concentrations of fluoxetine and its major metabolite for pharmacokinetic studies 1-gen-2009 Franceschi, Loretta; Faggiani, Anna; Furlanut, Mario
Acute oxcarbazepine, benazepril and hydrochlorothiazide overdose with alcohol 1-gen-2006 Furlanut, Mario; Franceschi, Loretta; Poz, D; Silvestri, L; Pecorari, M.
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 1-gen-1998 Damiani, Daniela; Michieli2, M2; Ermacora3, A3; Russo4, D4; Fanin, Renato; Zaja, Francesco; Baraldo, Massimo; Pea, Federico; Furlanut, Mario; Baccarani, Michele
AM and PM C2 monitoring of cyclosporine in liver transplant recipients 1-gen-2003 Baraldo, Massimo; Pavan, F; Brollo, L; Di Qual, E; Franceschi, L; Furlanut, Mario
Antimicrobial agents in elective surgery: Prophylaxis or "early therapy"? 1-gen-2003 Pea, F.; Viale, P.; Furlanut, M.
Antimicrobial therapy in critically ill patients: A review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability 1-gen-2005 Pea, Federico; Viale, Pierluigi; Furlanut, Mario
Blood concentrations and clinical effect of cyclosporin in psoriasis 1-gen-1996 Furlanut, Mario; Baraldo, Massimo; Pea, Federico; Marzocchi, V.; Croattino, L.; Galla, F.
C(2) monitoring of cyclosporine in stable heart transplant patients after two daily and three daily doses. 1-gen-2002 Baraldo, Massimo; Francesconi2, Anna2; Barbone, Fabio; Tursi4, Vincenzo4; Livi, Ugolino; Furlanut, Mario
Calculating percentage prediction error: a user's note 1-gen-1995 Wu, Guang; Baraldo, Massimo; Furlanut, Mario
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure 1-gen-2005 Pea, F; Viale, P; Damiani, D; Pavan, F; Cristini, F; Fanin, R; Furlanut, M
Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis 1-gen-2001 Scotton, Pg; Pea, Federico; Giobbia, M; Baraldo, Massimo; Vaglia, A; Furlanut, Mario
Chlorpromazine disposition in relation to age in children 1-gen-1990 Furlanut, Mario; Benetello, P; Baraldo, Massimo; Zara, G; Montanari, G; Donzelli, F.
Chronopharmacokinetics of ciclosporin and tacrolimus 1-gen-2006 Baraldo, Massimo; Furlanut, Mario
Ciprofloxacin disposition in elderly patients with LRTI being treated with sequential therapy (200 mg intravenously twice daily followed by 500 mg per os twice daily): Comparative pharmacokinetics and the role of therapeutic drug monitoring 1-gen-2000 Pea, Federico; Baraldo, Massimo; Lugatti, Emilio; Talmassons, Giovanni; Furlanut, Mario; Milaneschi, R
Circadian variations in cyclosporine C2 concentrations during the first 2 weeks after liver transplantation. 1-gen-2003 Baraldo, Massimo; Risaliti, Andrea; Bresadola, Fabrizio; Chiarandini, Paolo; DELLA ROCCA, Giorgio; Furlanut, Mario
Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients 1-gen-2008 Pea, F; Pavan, F; Furlanut, Mario; Pea, Federico
Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis 1-gen-1996 Furlanut, Mario; Baraldo, Massimo; Galla3, F3; Marzocchi4, V4; Pea, Federico
Cyclosporin nephrotoxicity in relation to its pharmacokinetics in man 1-gen-1997 Furlanut, Mario; Baraldo, Massimo; Pea, Federico
Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy 1-gen-1999 Baraldo, Massimo; Ferraccioli, Gianfranco; Pea, Federico; Gremese4, E4; Furlanut, Mario